Zhang Wengang, Linghu En-Qiang
Department of Gastroenterology, Chinese PLA General Hospital, No. 28, Fuxing Road, Haidian District, Beijing, 100853, China.
J Gastrointest Surg. 2017 May;21(5):785-791. doi: 10.1007/s11605-017-3398-x. Epub 2017 Mar 17.
There are only few studies about the outcomes of peroral endoscopic myotomy (POEM) for type III achalasia in a relatively large population to date. The purpose of this study was to explore the long-term efficacy of POEM for patients with type III achalasia.
There were a total of 32 consecutive patients with type III achalasia undergoing POEM in our hospital from July 2012 to October 2014. Clinical date of general characteristics, procedure-related parameters and adverse events, symptom relief, and the high-resolution manometry outcomes before and during the periodic follow-up were retrospectively collected and analyzed.
All of the 32 patients underwent POEM successfully with a median operation time of 34.9 min (range 17.9-88.6 min). No serious complications related to POEM were encountered. Treatment success was achieved in 90.6% cases during a median follow-up period of 27.0 months (range 24-51 months). The mean pretreatment and post-treatment Eckardt scores were 7.2 and 1.4, respectively (P < 0.001), and mean LES pressure also decreased from a mean of 39.2 to 19.0 mmHg after the procedure (P < 0.001). Both of the gas-related complication and clinical reflux complication rates were 18.8%.
Our results confirm that POEM for type III achalasia of Chicago Classification is effective with a long-term symptom relief in 90.6% cases. But a further, prospective study is needed to evaluate whether POEM outcome could be correlated with manometric subtypes according to Chicago Classification.
迄今为止,在相对较大规模人群中针对III型贲门失弛缓症进行经口内镜下肌切开术(POEM)治疗效果的研究较少。本研究旨在探讨POEM治疗III型贲门失弛缓症患者的长期疗效。
2012年7月至2014年10月期间,我院共有32例连续的III型贲门失弛缓症患者接受了POEM治疗。回顾性收集并分析了患者的一般特征、手术相关参数及不良事件、症状缓解情况以及定期随访前后的高分辨率测压结果等临床数据。
32例患者均成功接受了POEM治疗,中位手术时间为34.9分钟(范围17.9 - 88.6分钟)。未遇到与POEM相关的严重并发症。在中位随访期27.0个月(范围24 - 51个月)内,90.6%的病例治疗成功。治疗前和治疗后的平均埃卡德特评分分别为7.2和1.4(P < 0.001),术后平均LES压力也从39.2 mmHg降至19.0 mmHg(P < 0.001)。气体相关并发症和临床反流并发症发生率均为18.8%。
我们的结果证实,针对芝加哥分类法中的III型贲门失弛缓症,POEM治疗有效,90.6%的病例可实现长期症状缓解。但需要进一步开展前瞻性研究,以评估POEM治疗效果是否可根据芝加哥分类法与测压亚型相关联。